Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem, Jennifer Yost, Itziar Etxeandia-Ikobaltzeta, George M Abraham, Janet A Jokela, Mary Ann Forciea, Matthew C Miller, Linda L Humphrey

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)673-679
Number of pages7
JournalAnnals of internal medicine
Issue number5
StatePublished - May 1 2021


  • COVID-19
  • severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Pandemic
  • Coronavirus
  • Remdesivir

ASJC Scopus subject areas

  • Internal Medicine

Cite this